European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC - Nast, A; Gisondi, P; Ormerod, A D; Saiag, P; Smith, C; Spuls, P I; Arenberger, Petr; Bachelez, H; Barker, J; Dauden, E; de Jong, E M; Feist, E; et al. (Journal of the European Academy of Dermatology and Venereology, 2015)
Keywords: etanercept; antiflogistika nesteroidní; fumaráty; psoriáza; Ustekinumab; keratolytika; adalimumab; lidé; Immunosuppressive Agents; cyklosporin; Acitretin; Methotrexate; Anti-Inflammatory Agents, Non-Steroidal; Keratolytic Agents; methotrexát; Cyclosporine; kombinovaná farmakoterapie; Etanercept; acitretin; Psoriasis; Fumarates; imunosupresiva; Adalimumab; ustekinumab; Drug Therapy, Combination; Humans